BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Amniocentesis
,
Valproic acid
,
rs4950928
,
MYC
,
Apoptosis
,
Diabetes mellitus
,
Hippocampus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
inno 406
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for inno 406
Explore Curated Studies Results
Literature
Most Relevant Literature
INNO-406 inhibits the growth of chronic myeloid leukemia and promotes its apoptosis via targeting PT…
KIT polymorphisms and mutations determine responses of neoplastic mast cells to bafetinib (INNO-406)…
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profili…
Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and AB…
Phase 1 study of INNO-406, a dual Abl/Lyn kinase inhibitor, in Philadelphia chromosome-positive leuk…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leu…
Study of Bafetinib (INNO-406) as Treatment for Patients With Hormone-Refractory Prostate Cancer
Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CL…
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ